Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
| Cat.No. | Product Name | Price |
|---|---|---|
| CSC-RI0140 | Human KCND3 Stable Cell Line-CHO-K1 | Inquiry |
| CSC-RI0141 | Human KCND3 Stable Cell Line-HEK293 | Inquiry |
| CSC-DC007938 | Panoply™ Human KCND3 Knockdown Stable Cell Line | Inquiry |
| CSC-SC007938 | Panoply™ Human KCND3 Over-expressing Stable Cell Line | Inquiry |
| Cat.No. | Product Name | Price |
|---|---|---|
| AD08394Z | Human KCND3 adenoviral particles | Inquiry |
| LV15935L | human KCND3 (NM_172198) lentivirus particles | Inquiry |
| LV15936L | human KCND3 (NM_004980) lentivirus particles | Inquiry |
| Cat.No. | Product Name | Price |
|---|---|---|
| SHH322903 | shRNA set against Human KCND3 (NM_004980.4) | Inquiry |
| SHH322907 | shRNA set against Mouse KCND3 (NM_019931.1) | Inquiry |
| SHL181954 | shRNA set against Mouse Kcnd3(NM_001039347.1) | Inquiry |
| SHL182064 | shRNA set against Mouse Kcnd3(NM_019931.1) | Inquiry |
| SHW004842 | shRNA set against Chicken KCND3 (NM_204326) | Inquiry |
| SHW016074 | shRNA set against Danio rerio KCND3 (NM_199802) | Inquiry |
| Cat.No. | Product Name | Price |
|---|---|---|
| CDCS412044 | Human KCND3 ORF Clone (BC113475) | Inquiry |
| CDFG018378 | Mouse Kcnd3 cDNA Clone(NM_001039347.1) | Inquiry |
| CDFL006424 | Mouse Kcnd3 cDNA Clone(NM_019931.1) | Inquiry |
| MiUTR1M-06213 | KCND3 miRNA 3'UTR clone | Inquiry |
| MiUTR1M-06214 | KCND3 miRNA 3'UTR clone | Inquiry |
| MiUTR3H-07638 | KCND3 miRNA 3'UTR clone | Inquiry |
| MiUTR3H-07639 | KCND3 miRNA 3'UTR clone | Inquiry |
| CDCB166317 | Chicken KCND3 ORF Clone (NM_204326) | Inquiry |
| CDCB177549 | Danio rerio KCND3 ORF Clone (NM_199802) | Inquiry |
| CDCB181173 | Rabbit KCND3 ORF clone (NM_001082717.1) | Inquiry |
| CDCL122875 | Human Kcnd3 ORF clone (NM_019931.1) | Inquiry |
| CDCL122877 | Mouse Kcnd3 ORF clone (NM_001039347.1) | Inquiry |
| CDCR379887 | Rat Kcnd3 ORF Clone(NM_031739.3) | Inquiry |
| CDCS412043 | Human KCND3 ORF Clone (BC113477) | Inquiry |
Recent Research
KCND3 encodes the voltage-gated potassium channel Kv4.3, a membrane protein that consists of six trans-membrane segments (S1-S6) and two intra- cellular tails. Four Kv4.3 subunits co-assemble to form the pore domain (helices S5-S6), the potassium selective conduction pathway. The S1-S4 segments form a single voltage-sensor domain that surrounds the pore domain, connected by the S4-S5 loop, and responds to changes in membrane voltages controlling the pore gates. Kv4.3 rapidly activates and inactivates in response to membrane depolarization, contributing to the neuronal subthreshold A-type potassium currents and controlling the action potential repolarization and frequency, and thus neuronal excitability. The channel characteristics of Kv4.3 including protein trafficking, channel expression and activity can be modified by Kv channel-interacting protein 2 (KChIP).
Kv4.3 is a Shal-related subfamily, involved in the transient outward A-type Kb current in the neurons, Kv4.3 channels are important molecular components of transient K+ currents (Ito currents) in brain and heart. It has been reported that mutations in KCND3 either impaired proper endoplasmic reticulum (ER)–Golgi membrane trafficking or reduced Kv4.3 channel functioning. Kv4.3 channels are involved in setting the frequency of neuronal firing and heart pacing. Altered Kv4.3 channel expression has been demonstrated under pathological conditions like heart failure indicating their critical role in heart function. Thyroid hormone studies suggest that their expression in the heart may be hormonally regulated. In addition, spinocerebellar ataxia type 19/22 (SCA19/22) is a dominantly inherited neurodegenerative, clinically heterogeneous disorder caused by mutations in KCND3. Currently, all the SCA19/22 mutations that have been reported lead to a loss of Kv4.3 current amplitude in studies focused on single mutant Kv4.3 subunits. Besides, multiple mutations in KCND3 have been reported to be associated with the pathogenesis of Brugada syndrome (BrS) and sudden unexplained death syndrome. Moreover, atrial fibrillation (AF) is the most common sustained cardiac arrhythmia that results in serious cardiovascular outcomes such as stroke, heart failure and death. It has been identified a novel T361S missense mutation, which is connected with AF, in KCND3.The T361S mutant result in the changes in channel kinetics as well as the up-regulation of Kv4.3 protein.
References: